Biocad is developing an mRNA vaccine candidate for COVID-19. Development will be based on previous pipelines for mRNA-oncovaccines creation.
Lead Product(s): SARS-COV-2 mRNA vaccine
Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed
Highest Development Status: Discovery Product Type: Vaccine
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable March 19, 2020